OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2024-03-31-accounts

Charity registration number 1078956

Company registration number 03640937 (England and Wales)

CHAI-LIFELINE CANCER CARE

(A COMPANY LIMITED BY GUARANTEE)

ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) LEGAL AND ADMINISTRATIVE INFORMATION

Trustees S. Zuckerbrod L. Hager A. Tookman R. Segal A. Maurice P. Hertz L. Shelley R. Saville (Appointed 18 August 2023) Charity number 1078956 Company number 03640937 Registered office 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX Auditor Landau Morley LLP 325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) CONTENTS

Page
Trustees' report 1 - 8
Independent auditor's report 9 - 11
Statement of financial activities 12
Balance sheet 13
Statement of cash flows 14
Notes to the financial statements 15 - 28

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) FOR THE YEAR ENDED 31 MARCH 2024

The Trustees (who are also directors for the purpose of the Companies Act) present their annual report together with the audited financial statements of Chai-Lifeline Cancer Care (the company) for the year ended 31 March 2024.

The Trustees confirm that the Annual report and financial statements of the company comply with the current statutory requirements, have been prepared in accordance with the accounting policies set out in the notes to the financial statements and comply with the charity's governing document, the Companies Act 2006 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)".

Since the company qualifies as small under section 383, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director’s Report) Regulations 2013 is not required.

Reference and Administrative Details

Reference and administrative details are shown in the schedule of members of the board and professional advisors on the legal and administrative information page of the financial statements.

Structure, Governance and Management

Chai-Lifeline Cancer Care is a company limited by guarantee governed by its Memorandum and Articles of Association dated 24[th] September 1998 as amended by written resolution on 7[th] August 2012. It has no share capital. It is a registered charity, Charity number 1078956. The charity is governed by the Companies Act 2006 and the Charities Act 2011.

Appointment of Trustees, Induction and Training

Trustees may be recruited from the Jewish Community. They will be able to demonstrate an ability to support, promote and lead development of the charity. They will have an area of expertise that will enhance the work of the Trustees and contribute to the achievement of the charity’s objectives.

New Trustees undergo induction training to brief them on their legal obligations under charity and company law, the content of the Memorandum and Articles of Association, the committee and decision-making processes, the objectives and financial performance of the charity. Trustees are encouraged to attend appropriate external training events where these will facilitate the undertaking of their role.

Organisation

The Board of Trustees administers and determines the general policy of the charity.

The Chief Executive, Lisa Steele, is appointed by the Trustees to manage the day-to-day operations of the charity with delegated responsibility.

The vast majority of Chai’s staff provides face to face services for clients.

Related Parties

In the year ended 31[st] March 2024, the charity did not undertake any transactions with related parties other than those disclosed in the financial statements.

Risk Management

The Trustees assess the major risks to which the charity is exposed and implement systems to mitigate both financial and non-financial risks.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Chai has a risk register which is reviewed regularly. The Trustees also ensure that clinical governance is in place, throughout all service areas of therapy, complementary therapy and counselling, and physical and psychological groups.

Chai operates a high level of confidentiality with respect to all client information.

Achievable fundraising targets are set to cover realistic budgets, which are monitored on a monthly basis together with cash forecasts.

Objectives and Activities

The objectives of the charity are:

To promote the relief of persons suffering from cancer and their families within the Jewish Community and to prevent sickness by promoting good health care and the provision of education and screening programmes for persons within the Jewish community, whether suffering from cancer or not.

The charity has the general aim of providing an extensive range of services including counselling, therapies, complementary therapies, advocacy, legal, financial and spiritual advice, group activities and support groups for the Jewish community.

Chairman’s statement

The past year has been one of continued development for the organisation, as Chai responds to unprecedented demand across the community.

At the forefront of this activity is Chai’s active role in raising awareness of the NHS England Jewish BRCA genetic population testing programme. This ground breaking initiative has been developed to identify any person over 18, with at least one Jewish grandparent, for the mutated BRCA1/ BRCA 2 gene.

Following the official launch at the House of Lords in January, over 17,000 people have expressed interest to be tested.

Chai’s reputation as a leader and innovator in the field of supportive cancer care goes beyond the Jewish Community. A notable example was when Chai was commended in Parliament by Nicola Richards MP for “developing a blueprint for how to best support those affected by cancer. I take away a lot from their approach.”

The combination of earlier diagnoses and advances in surgery and treatment mean that thankfully more people are living for longer, albeit with physical and emotional changes which affect both the cancer patients and their family members. Our clients often refer to us as the constant factor during a time of great uncertainty in their lives.

To meet the relentless demand, we invested in the infrastructure of our North West Service as well as recruiting additional counsellors and therapists.

Chai does not receive any statutory funding but was able to continue to provide specialised services mainly through a matched funding campaign which also afforded the opportunity to inform the community of the comprehensive range of support services which Chai provides.

What Chai provides

Chai provides services to the Jewish community and these can be accessed either by self-referral or referral from a professional.

Chai’s reputation for providing a highly professional service combined with sensitivity and care has encouraged those needing our service to contact us. Services are provided from our flagship centre in Hendon and from our 11 satellite centres across the UK. For those unable to access a Chai site, support will be provided through telephone counselling, Skype and Zoom, nationally and internationally. Awareness of our services has built significantly with enquiries from Israel, USA, Canada, Australia, Europe and South Africa.

Chai services provided to clients are:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Many of the support groups are online to allow our clients to join nationally. This has proved particularly beneficial for clients not within geographical reach of a Chai centre.

Objectives for 2023/2024

All objectives were achieved.

Major areas of Fundraising activity

Performance and achievements in 2023/2024

To meet our clients’ many and diverse needs, Chai now provides 68 specialised support services across the nationwide network of 11 satellite centres. For those who are not able to come to us, services can be provided in clients’ own homes, hospitals and hospices through our Home Support Services. In addition, clients can still access our expertise and care, including some groups, through Zoom.

The feedback from our clients, both the cancer patients and their family members, is that our services make a tangible difference and that this ongoing support brings considerable relief and comfort. Without it their lives would be of poorer quality, as there is nowhere else for them to receive this level of specialised support.

Following the soft launch in January 2023 and the official launch in January 2024 of the NHS England Jewish BRCA Testing Programme, the need for Chai’s expertise has risen. Whilst the knowledge of testing positive for a mutated BRCA1 /BRCA2 gene for can save lives, the impact can be overwhelming, not only for the person themselves, but also for their family members. We have increased our specialised support and now provide 1 to 1, couple and family support as well as two support groups, one for people with cancer and one for those without cancer.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

We continue to receive calls for our ‘Chai in Schools’ programme from Primary and Secondary schools across the UK. This is due to the increase in the number of parents being diagnosed with cancer, many of whom have children. In addition to supporting the children during school hours, and in the holidays at a Chai centre, we provide practical advice and strategies to teachers, many of whom have not had experience of dealing with terminal illness.

Service Activity

Number of New Clients:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Developing Services

Chai’s Medical Advisory Panel ensures that Chai is kept updated on all developments of cancer treatment and care. This knowledge, together with our clients’ feedback, enables us to refine and plan the range of services that are needed to meet the complex and evolving needs of our clients.

Chai continues to raise awareness of the lifesaving potential of the NHS England Jewish BRCA Testing Programme. With people in the Jewish population six times more likely to carry a mutated gene, Chai’s specialised counsellors receive training from the Royal Marsden and Northwick Park genetics team to enable them to support all those who wish to discuss the implications of being tested as well as those who test positive for a mutated gene.

We developed the BRCA support group for those who have tested positive, but do not have cancer.

New services include pelvic floor physiotherapy and a creative writing workshop.

Managing the long-term physical and emotional impact of living with a cancer diagnosis is an on-going challenge for our clients. However, with counsellors providing expert support and with the breadth of our complementary and therapeutic treatments, Chai makes a significant difference to people’s lives.

Fundraising

A matched funding campaign in December was successful in both raising funds and awareness.

Chai’s two annual appeals, Pesach and Rosh Hashana were both successful.

We were able to hold the annual Club 18 Golf Day and the biennial Golf Fore Chai Day, a Whisky Event, The Ladies Lunch, and Rosh Hashana Gift Sale.

Quality assurance

A specialist independent consultant has reviewed all Chai’s policies and all members of staff have attended GDPR awareness and training sessions across the UK Chai centres.

Chai continues to use the quality assurance scheme to assist it in monitoring the quality of its services and to contribute to the future development of new services. The system is an accredited tool which is used nationally in cancer support organisations. The system is called MYCaW (Measure Yourself Concerns and Wellbeing) and is used for most clients who use Chai’s services.

The Counsellors’ Handbook and Complementary Therapists’ handbook have both been reviewed and are used across all of our sites to clarify processes and to ensure consistency throughout the organisation.

Chai’s Staff Handbook has again been updated in line with current legislation.

The Volunteers’ Handbook has been reviewed and constantly updated.

All further policies are reviewed and constantly updated.

Training for therapists and counsellors, including continued professional development, is provided.

Three external Counselling Supervisors support the Psychological Teams nationally.

The annual Natalie Shipman Memorial Lecture took place in November 2023. Professor Ruth Plummer, Professor of Experimental Cancer Medicine, Newcastle University, spoke about ‘Taking new cancer drugs to the patient’.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Objectives for 2024/2025

Financial review

Donations received from all sources amounted to £3,819,861 (2022/23: £4,334,865) representing a 11.88% decrease from last year.

Funds were raised from specific major fundraising and community events, appeals, private donations, legacies, patronage campaign and commemorative giving.

Chai also received unsolicited donations.

During the year Chai expended:

Cost of providing services - £3,218,831 (2022/23: £2,750,606)

Fundraising and publicity costs - £641,054 (2022/23: £612,610)

Governance costs - £18,101 (2022/23: £23,393)

Annual accounts are delivered to the Charity Commission within 10 months of the financial year-end.

Financial Health

At 31[st] March 2024 there was a net surplus of income for the year of £531,775 (2022/23: £789,987).

Disclosure of Trustee remuneration

See note 10 to the accounts.

Investments

See note 14 to the accounts.

The charity’s wholly owned subsidiary Chai-Lifeline Services Ltd remains dormant. At 31st March 2024 this company’s reserves totalled £2.

The Trustees have adopted a low-risk strategy to the investment of the charity’s funds. The aim of the investment activity is to obtain a reasonable balance between capital growth and income so the charity can meet future demands as well as current needs.

The charity’s investment holdings are currently managed by two independent investment managers, with whom cautious investment mandates have been agreed. The investment managers report on performance and compliance with their mandates on a regular basis. The Trustees regularly monitor the levels of investments and the returns received to generate sufficient financial return to enable the charity to achieve its Objectives effectively and without interruption.

The charity’s investment holdings are diversified by additional holdings in current and short-term cash deposits.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Volunteers

Chai currently has 120 volunteers who work on behalf of the charity in a variety of roles including befriending, transport, reception duties and administration. The average volunteer spends 2-3 hours a week assisting Chai. All volunteers receive initial training and ongoing supervision.

Reserves Policy

The trustees are committed to meeting the expectations of all clients turning to Chai for support and continue to explore unmet need. No client is turned away and no statutory funding is received.

Our charity supports very sick people and those who are close to them. Our activities include offering educational resources for patients, carers and professionals and our future plans are to proactively explore innovative methods of health promotion with our clientele. In view of the nature of the illness we frequently have a long term commitment with our patients and their families. The Trustees therefore think the charity's reserves policy should reflect this long term engagement and Chai is aiming to build sufficient unrestricted free funds to cover at least one year's future operational costs, for the sake of prudence.

The Trustees have allocated £1m towards an upcoming building project at the Flagship Centre in NW London.

At 31 March 2024 free reserves are £2,006,858 (2023: £2,997,703). The management team continue to put a strong emphasis on building these reserves and have a programme of financial planning to accumulate and sustain these reserves, which will need to increase in line with the finances required to fund the growing number of clients using the services for increasing periods of time.

Trustees

The Trustees, who are also the directors for the purpose of company law, and who served during the year and up to the date of signature of the financial statements were:

S. Zuckerbrod

L. Hager

A. Tookman

R. Segal

A. Maurice

P. Hertz

L. Shelley

R. Saville

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) TRUSTEES' REPORT (INCLUDING DIRECTORS' REPORT) (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

Statement of Trustees' responsibilities

The Trustees, who are also the directors of Chai-Lifeline Cancer Care for the purpose of company law, are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company Law requires the Trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that year.

In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to auditor

Each of the Trustees has confirmed that there is no information of which they are aware which is relevant to the audit, but of which the auditor is unaware. They have further confirmed that they have taken appropriate steps to identify such relevant information and to establish that the auditor is aware of such information.

This report was approved by the Trustees on 20 December 2024 and signed on their behalf by:

L. Hager Trustee

R. Segal Trustee

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Opinion

We have audited the financial statements of Chai-Lifeline Cancer Care (the ‘charity’) for the year ended 31 March 2024 which comprise the statement of financial activities, the balance sheet, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion, the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the charity in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The Trustees are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters in relation to which the Charities (Accounts and Reports) Regulations 2008 require us to report to you if, in our opinion:

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

Responsibilities of Trustees

As explained more fully in the statement of Trustees' responsibilities, the Trustees, who are also the directors of the charity for the purpose of company law, are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the Trustees are responsible for assessing the charity’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

We have been appointed as auditor under section 144 of the Charities Act 2011 and report in accordance with the Act and relevant regulations made or having effect thereunder.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK).

The potential effects of inherent limitations are particularly significant in the case of misstatement resulting from fraud because fraud may involve sophisticated and carefully organized schemes designed to conceal it, including deliberate failure to record transactions, collusion or intentional misrepresentations being made to us.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF CHAI-LIFELINE CANCER CARE

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https:// www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the charity’s trustees, as a body, in accordance with part 4 of the Charities (Accounts and Reports) Regulations 2008. Our audit work has been undertaken so that we might state to the charity's trustees those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charity and the charity’s trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Landau Morley LLP Chartered Accountants Statutory Auditor

20 December 2024

325-327 Oldfield Lane North Greenford Middlesex UB6 0FX

Landau Morley LLP is eligible for appointment as auditor of the charity by virtue of its eligibility for appointment as auditor of a company under section 1212 of the Companies Act 2006.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 MARCH 2024

Unrestricted
Unrestricted
funds
funds
2024
2023
Notes
£
£
Income from:
Donations and legacies
3
3,819,861
4,319,865
Investments
4
186,021
69,876
Total income
4,005,882
4,389,741
Expenditure on:
Raising funds
5
641,054
612,610
Charitable activities
6
3,218,831
2,666,801
Total expenditure
3,859,885
3,279,411
Net gains/(losses) on investments
11
385,778
(251,538)
Net income
531,775
858,792
Transfers between funds
-
3,207,067
Net movement in funds
8
531,775
4,065,859
Reconciliation of funds:
Fund balances at 1 April 2023
12,555,976
8,490,117
Fund balances at 31 March 2024
13,087,751
12,555,976		 Restricted
funds
2023
£
15,000
-
15,000
-
83,805
83,805
-
(68,805)
(3,207,067)
(3,275,872)
3,275,872
-		 Total
2023
£
4,334,865
69,876
4,404,741
612,610
2,750,606
3,363,216
(251,538)
789,987
-
789,987
11,765,989
12,555,976

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) BALANCE SHEET

AS AT 31 MARCH 2024

Notes
Fixed assets
Tangible assets
13
Investments
14
Current assets
Debtors
16
Investments
17
Cash at bank and in hand
Creditors: amounts falling due within
one year
18
Net current assets
Total assets less current liabilities
Income funds
Unrestricted funds
Designated funds
21
General unrestricted funds		 2024
£
£
4,576,662
6,504,231
11,080,893
306,702
1,250,000
743,610
2,300,312
(293,454)
2,006,858
13,087,751
1,000,000
12,087,751
13,087,751
13,087,751		 2023
£
£
4,677,793
4,880,480
9,558,273
296,291
674,202
2,351,756
3,322,249
(324,546)
2,997,703
12,555,976
1,000,000
11,555,976
12,555,976
12,555,976		 2023
£
£
4,677,793
4,880,480
9,558,273
296,291
674,202
2,351,756
3,322,249
(324,546)
2,997,703
12,555,976
1,000,000
11,555,976
12,555,976
12,555,976
9,558,273
2,997,703
12,555,976
12,555,976
12,555,976

The company is entitled to the exemption from the audit requirement contained in section 477 of the Companies Act 2006, for the year ended 31 March 2024, although an audit has been carried out under section 144 of the Charities Act 2011.

The directors acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements under the requirements of the Companies Act 2006, for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Trustees on 20 December 2024

L. Hager R. Segal
Trustee Trustee
Company Registration No. 03640937

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 MARCH 2024

2024 2023
Notes £ £ £ £
Cash flows from operating activities
Cash generated from operations 25 71,614 1,179,703
Investing activities
Purchase of tangible fixed assets (52,011) (78,361)
Purchase of investments (2,301,970) (1,019,589)
Proceeds from disposal of investments 488,200 (1,737)
Investment income received 186,021 69,876
Net cash used in investing activities (1,679,760) (1,029,811)
Net cash used in financing activities - -
Net (decrease)/increase in cash and cash
equivalents (1,608,146) 149,892
Cash and cash equivalents at beginning of year 2,351,756 2,201,864
Cash and cash equivalents at end of year 743,610 2,351,756

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

1 Accounting policies

Charity information

Chai-Lifeline Cancer Care is a private company limited by guarantee incorporated in England and Wales. The registered office is 325-327 Oldfield Lane North, Greenford, Middlesex, UB6 0FX.

1.1 Accounting convention

The financial statements have been prepared in accordance with the charity's governing document, the Companies Act 2006 and “Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)” (as amended for accounting periods commencing from 1 January 2019).

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the Trustees have a reasonable expectation that the Charity has adequate resources to support the current level of expenditure and to continue in operational existence for the foreseeable future.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the Trustees in furtherance of their charitable objectives.

Restricted funds are subject to specific conditions by donors or grantors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Fundraising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities. Support costs are those costs incurred directly in support of expenditure on the objects of the company and include project management carried out at Headquarters. Governance costs are those incurred in connection with administration of the company and compliance with constitutional and statutory requirements.

Costs of generating funds are costs incurred in attracting voluntary income, and those incurred in trading activities that raise funds.

Charitable activities and Governance costs are costs incurred on the company's educational operations, including support costs and costs relating to the governance of the company apportioned to charitable activities.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold property 2% straight line Office equipment 15% straight line Fixtures and fittings 15% straight line Computer equipment 33% straight line

Freehold land and assets in the course of construction are not depreciated.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

A subsidiary is an entity controlled by the charity. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.8 Impairment of fixed assets

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

1 Accounting policies

(Continued)

1.9 Cash and cash equivalents

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.10 Financial instruments

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.11 Employee benefits

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.12 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2 Critical accounting estimates and judgements

In the application of the charity’s accounting policies, the Trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

3 Donations and legacies

Unrestricted
Unrestricted
funds
funds
2024
2023
£
£
General donations
372,360
372,684
Patronage
49,531
54,375
Legacies
162,562
701,483
New Year appeal
179,756
175,707
Pesach appeal
82,315
85,504
Golf days
118,324
43,685
Income from Dinner Function
3,659
9,782
Chai Challenge
-
79,740
Ladies Events
120,819
103,335
London Marathon
58,263
39,882
Manchester events
5,800
10,991
Other fundraising events
160,204
213,624
Service donations
178,078
186,386
Annual Campaigns
2,328,190
2,242,687
3,819,861
4,319,865		 Restricted
funds
2023
£
-
-
-
-
-
-
-
-
-
-
-
-
15,000
-
15,000		 Total
2023
£
372,684
54,375
701,483
175,707
85,504
43,685
9,782
79,740
103,335
39,882
10,991
213,624
201,386
2,242,687
4,334,865

4 Income from investments

Unrestricted Unrestricted
funds funds
2024 2023
£ £
Investment income 170,017 61,633
Interest receivable 16,004 8,243
186,021 69,876

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

5 Raising funds

Unrestricted
funds
2024
£
Fundraising and publicity
Fundraising costs
313,365
Staff costs
309,859
Fundraising and publicity
623,224
Investment management
17,830
641,054
Costs of Raising funds comprised:
2024
Fundraising and publicity
General donations
31,548
Patronage
5,128
Legacy costs
3,176
New Year appeal
36,940
Pesach appeal
23,733
Golf days
30,540
Dinner Function
309
Chai Challenge
-
Ladies Events
63,664
London Marathon
8,195
Manchester events
27,627
Other fundraising events
75,466
Services
15,087
Annual Campaigns
301,811
Total
623,224		 Total
2023
£
263,220
318,981
582,201
30,409
612,610
2023
31,712
6,987
3,280
34,813
22,252
11,918
832
6,786
56,213
7,056
28,470
43,588
17,136
311,158
582,201

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

6 Charitable activities

Staff costs
Freelance therapists' and consultants' costs
Publications costs
Advertising services
Training supervisor costs
Room hire costs
Patients' aids/Consumables
Laundry services
Other costs
Share of support costs (see note 7)
Share of governance costs (see note 7)
Analysis by fund
Unrestricted funds
Restricted funds		 2024
£
940,049
996,115
165,415
77,571
45,877
68,063
8,460
11,692
132,932
2,446,174
754,556
18,101
3,218,831
3,218,831
-
3,218,831		 2023
£
776,448
808,494
155,788
88,354
44,458
62,827
14,274
10,086
87,046
2,047,775
679,438
23,393
2,750,606
2,666,801
83,805
2,750,606

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

7 Support costs

Staff costs
Depreciation
Premises costs
Rates, water and
electricity
Newspapers and journals
Computer and internet
expenses
Telephone
Other costs
Postage and printing
Legal & Professional fees
Audit fees
Accountancy
Analysed between
Charitable activities		 Support
costs
Governance
costs
£
£
201,066
-
153,141
-
145,462
-
50,203
-
7,567
-
60,178
-
12,725
-
42,025
-
25,543
-
56,646
-
-
12,200
-
5,901
754,556
18,101
754,556
18,101		 2024Support costs Governance
costs
£
£
£
201,066
182,633
-
153,141
162,175
-
145,462
110,921
-
50,203
47,474
-
7,567
6,788
-
60,178
47,336
-
12,725
11,655
-
42,025
43,180
-
25,543
24,105
-
56,646
43,171
-
12,200
-
12,164
5,901
-
11,229
772,657
679,438
23,393
772,657
679,438
23,393		 2023
£
182,633
162,175
110,921
47,474
6,788
47,336
11,655
43,180
24,105
43,171
12,164
11,229
702,831
702,831

Governance costs include payments to the auditors of £12,200 (2023: £12,164) for audit fees and £5,901 (2023: £11,229) for non audit fees.

8 Net movement in funds 2024 2023
£ £
The net movement in funds is stated after charging/(crediting):
Fees payable for the audit of the charity's financial statements 12,200 12,164
Depreciation of owned tangible fixed assets 153,141 162,175

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

9 Employees

Number of employees

The average monthly number of employees during the year was:

Employment costs
Wages and salaries
Social security costs
Other pension costs		 2024
Number
31
2024
£
1,255,146
130,203
65,625
1,450,974		 2023
Number
29
2023
£
1,109,763
107,954
60,345
1,278,062

The key management personnel of the charity comprise one of the Trustees and the Chief Executive. The total employee benefits of the key management personnel of the Charity were £251,993 (2023: £228,775).

Of the employees whose emoluments exceed £60,000, 2 (2023: 3) have retirement benefits accruing under defined contribution pension schemes.

The number of employees whose annual remuneration was £60,000 or more were:

2024 2023
Number Number
In the band £60,001 - £70,000 - 1
In the band £90,001 - £100,000 1 1
In the band £110,001 - £120,000 - 1
In the band £130,001 - £140,000 1 -

10 Trustees' remuneration

The Charity Commission approved payments of remuneration, benefits in kind and pension contributions to Louise Hager, a trustee of the Charity, in her role as Chairman. Louise Hager promotes the charity nationally and internationally and leads the fundraising department. Payments are made pursuant to the authority set out in Article 5 of the Charity's Articles of Association.

Remuneration paid to the trustee (including benefits in kind and pension contributions) during the year ended 31 March 2024 totalled £145,944 (2023: £127,720).

During the year retirement benefits were accruing to 1 Trustee (2023: 1) in respect of defined contribution pension schemes.

No other Trustee received any remuneration or reimbursed expenses in the year.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

11 Gains and losses on investments

Unrestricted Unrestricted
funds funds
2024 2023
Gains/(losses) arising on: £ £
Revaluation of investments 385,778 (251,538)

12 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

13 Tangible fixed assets

Cost
At 1 April 2023
Additions
At 31 March 2024
Depreciation and impairment
At 1 April 2023
Depreciation charged in the year
At 31 March 2024
Carrying amount
At 31 March 2024
At 31 March 2023		 Freehold
property
£
6,205,048
10,560
6,215,608
1,630,633
102,712
1,733,345
4,482,263
4,574,415		 Office
equipment
Fixtures and
fittings
£
£
82,520
763,200
97
33,688
82,617
796,888
80,208
686,805
768
33,403
80,976
720,208
1,641
76,680
2,311
76,396		 Computer
equipment
£
268,618
7,666
276,284
243,948
16,258
260,206
16,078
24,671		 Total
£
7,319,386
52,011
7,371,397
2,641,594
153,141
2,794,735
4,576,662
4,677,793

Included in freehold property is land with a historic cost of £1,080,000 (2023: £1,080,000) that is not depreciated.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2024

14 Fixed asset investments

Managed Other Total
investments investments
£ £
Cost or valuation
At 1 April 2023 4,880,478 2 4,880,480
Additions 3,551,970 - 3,551,970
Valuation changes 385,778 - 385,778
Transfer to current assets (1,250,000) - (1,250,000)
Disposals (1,063,997) - (1,063,997)
At 31 March 2024 6,504,229 2 6,504,231
Carrying amount
At 31 March 2024 6,504,229 2 6,504,231
At 31 March 2023 4,880,478 2 4,880,480
2024 2023
Other investments comprise: Notes £ £
Investments in subsidiaries 24 2 2
15 Financial instruments
2024 2023
£ £
Carrying amount of financial assets
Instruments measured at fair value through profit or loss 1,250,000 674,202
16 Debtors
2024 2023
Amounts falling due within one year: £ £
Income tax recoverable and other debtors 221,447 210,261
Prepayments and accrued income 85,255 86,030
306,702 296,291

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

17 Current asset investments

Unlisted investments

2024 2023
£ £
1,250,000 674,202

Current asset investments comprise fixed term deposits of £Nil (2023: £174,202) held in the UK and overseas bonds of £1,250,000 (2023: £500,000) in Israel.

18 Creditors: amounts falling due within one year

Creditors: amounts falling due within one year
Other taxation and social security
Trade creditors
Amounts owed to subsidiary undertakings
Accruals and deferred income		 2024
£
33,609
163,989
2
95,854
293,454		 2023
£
29,680
186,739
2
108,125
324,546

Accruals and deferred income include deferred income totalling £66,573 (2023: £64,189) in respect of amounts received in advance.

19 Retirement benefit schemes

Retirement benefit schemes
2024 2023
Defined contribution schemes £ £
Charge to profit or loss in respect of defined contribution schemes 65,625 60,345

The charity operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the charity in an independently administered fund.

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

20 Restricted funds

Chai Centre
Building Fund
Chai Centre
Extension
Building Fund
Chai Centre -
Outpatient
Rehabilitation
& Palliative
Care Service
Chai Centre -
Manchester		 Balance at
1 April 2022
£
1,761,115
1,445,844
-
68,913
3,275,872		 Movement in funds
Incoming
resources
Resources
expended
Transfers
£
£
£
-
(40,212)
(1,720,903)
-
(18,256)
(1,427,588)
15,000
(15,000)
-
-
(10,337)
(58,576)
15,000
(83,805)
(3,207,067)		 Movement
in funds
Balance at
1 April 2023
Incoming
resources
Balance at
31 March 2024
£
£
£
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-		 Movement
in funds
Balance at
1 April 2023
Incoming
resources
Balance at
31 March 2024
£
£
£
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

In the prior year the restricted funds relating to building projects undertaken by the charity had been transferred to the unrestricted fund as the building works were complete and the assets were used on an unrestricted basis for any charitable purpose.

21 Unrestricted funds

The unrestricted funds of the charity comprise the unexpended balances of donations and grants which are not subject to specific conditions by donors and grantors as to how they may be used. These include designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes.

Designated fund
General funds		 At 1 April
2023
£
1,000,000
11,555,976
12,555,976		 Incoming
resources
£
-
4,005,882
4,005,882		 Resources
expended
£
-
(3,859,885)
(3,859,885)		 Transfers
£
-
-
-		 Gains and
losses
At 31 March
2024
£
£
-
1,000,000
385,778
12,087,751
385,778
13,087,751		 Gains and
losses
At 31 March
2024
£
£
-
1,000,000
385,778
12,087,751
385,778
13,087,751
13,087,751

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

21 Unrestricted funds

Unrestricted funds
Previous year:
Designated fund
General funds		 At 1 April
2022
£
-
8,490,117
8,490,117		 Incoming
resources
£
-
4,389,741
4,389,741		 Resources
expended
£
-
(3,279,411)
(3,279,411)		 Transfers
£
1,000,000
2,207,067
3,207,067		 (Continued)
Gains and
losses
At 31 March
2023
£
£
-
1,000,000
(251,538)
11,555,976
(251,538)
12,555,976

Designated funds represent amounts sent aside by the trustees in order to accumulate funds towards a future capital project at the Flagship Centre in NW London.

22 Related party transactions

Donations of £30,873 (2023: £48,271) were received during the year from the Trustees and from entities connected with the Trustees.

23 Controlling Party

The company is limited by guarantee and under the control of the Trustees.

24 Subsidiaries

Details of the charity's subsidiary at 31 March 2024 are as follows:

Name of undertaking Registered Nature of business Class of % Held
office shares held Direct Indirect
Chai-Lifeline Services England & Wales Dormant Ordinary 100 -
Limited

The aggregate capital and reserves and the result for the year of subsidiaries excluded from consolidation was as follows:

Name of undertaking Profit/(Loss) Capital and
Reserves
£ £
Chai-Lifeline Services
Limited 2

CHAI-LIFELINE CANCER CARE (A COMPANY LIMITED BY GUARANTEE) NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 MARCH 2024

25
Cash generated from operations
Surplus for the year
Adjustments for:
Investment income recognised in statement of financial activities
Fair value gains and losses on investments
Depreciation and impairment of tangible fixed assets
Movements in working capital:
(Increase) in debtors
(Decrease)/increase in creditors
Cash generated from operations
26
Analysis of changes in net funds		 2024
£
531,775
(186,021)
(385,778)
153,141
(10,411)
(31,092)
71,614		 2023
£
789,987
(69,876)
251,538
162,175
(7,651)
53,530
1,179,703

The charity had no material debt during the year.